Please check your internet connection and try again.
# Walethmade bromide
## Overview
"Walethmade bromide" is not a recognized generic pharmaceutical agent, international nonproprietary name (INN), or brand name product. It is possible this is a misspelling of **Aclidinium bromide** (a long-acting muscarinic antagonist) or another similar sounding respiratory/antispasmodic agent. Please verify the spelling or provide the brand name to ensure clinical accuracy.
## Primary Indications
If referencing Aclidinium bromide: Maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
## Adult Dosing
If Aclidinium bromide: 400 mcg inhaled twice daily.
## Pediatric Dosing
Safety and efficacy have not been established in the pediatric population.
## Dose Adjustments
No specific dosage adjustments are required for elderly patients or patients with renal or hepatic impairment.
## Contraindications
Hypersensitivity to the active substance or milk proteins (lactose). Not indicated for the relief of acute bronchospasm.
## Adverse Effects
Common: Headache, nasopharyngitis, cough, sinusitis.
Serious: Paradoxical bronchospasm, urinary retention, worsening of narrow-angle glaucoma.
## Key Drug Interactions
Avoid concomitant use with other anticholinergic medications (e.g., ipratropium, tiotropium) due to the risk of additive anticholinergic systemic effects.
## Monitoring
Monitor for signs of paradoxical bronchospasm, urinary retention, and worsening ocular symptoms (e.g., blurred vision, eye pain) in patients with narrow-angle glaucoma.
## Clinical Pearls
If this agent were an anticholinergic:
* Ensure the patient understands that the inhaler is for maintenance only, not rescue therapy.
* Instruct the patient to rinse their mouth with water after administration to prevent oral candidiasis (if combined with corticosteroids) or dryness.
* If this is a misspelling of a different compound, please resubmit the request with the correct chemical or brand name.
***
**Educational Disclaimer:** This information is provided for educational purposes only and does not constitute medical advice. Drug naming conventions and dosing guidelines change frequently. Always consult the latest package insert, the current *Physicians' Desk Reference* (PDR), or your local hospital formulary and pharmacy department to verify prescribing information before administration.